Westin Fredrik
Known title: See RemarksCIK: 0001805593
Associated companies
Transaction History
| ALV | ▲ Buy | Option Exercise | 3,629 | $0 | 2/19/2026 | View on chart |
| ALV | ▲ Buy | Option Exercise | 846 | $0 | 2/15/2026 | View on chart |
| ALV | ▼ Sell | Open Market | 1,803 | $179K | 2/25/2025 | View on chart |
| ALV | ▲ Buy | Option Exercise | 770 | $0 | 2/21/2025 | View on chart |
| ALV | ▲ Buy | Option Exercise | 2,836 | $0 | 2/21/2025 | View on chart |
| ALV | ▼ Sell | Open Market | 1,318 | $145K | 2/21/2024 | View on chart |
| ALV | ▲ Buy | Option Exercise | 1,881 | $0 | 2/20/2024 | View on chart |
| ALV | ▲ Buy | Option Exercise | 753 | $0 | 2/18/2024 | View on chart |
| ALV | ▼ Sell | Open Market | 1,505 | $147K | 3/6/2023 | View on chart |
| ALV | ▲ Buy | Option Exercise | 815 | $0 | 3/2/2023 | View on chart |
| ALV | ▲ Buy | Option Exercise | 2,194 | $0 | 3/2/2023 | View on chart |
| ALV | ▼ Sell | Open Market | 538 | $48K | 2/17/2023 | View on chart |
| ALV | ▲ Buy | Option Exercise | 1,076 | $0 | 2/15/2023 | View on chart |
| ALV | ▼ Sell | Open Market | 1,060 | $80K | 3/7/2022 | View on chart |
| ALV | ▲ Buy | Option Exercise | 2,120 | $177K | 3/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Autoliv Retires Shares, Adds Research Board Members
Autoliv has retired shares repurchased during the period, which reduces the total number of issued shares outstanding. The company also strengthened its safety expertise by adding two new members to its Research Advisory Board. These corporate actions occurred while the stock traded near its 52-week low, with an average analyst target price of $134.31.
Autoliv Retires Shares, Adds Research Board Members. Autoliv has retired shares repurchased during the period, which reduces the total number of issued shares outstanding. The company also strengthened its safety expertise by adding two new members to its Research Advisory Board. These corporate actions occurred while the stock traded near its 52-week low, with an average analyst target price of $134.31.